Direct Healthcare Group (DHG), a leading European manufacturer of pressure care, specialist seating, patient handling, and bathroom safety solutions, has acquired Talley Group Ltd; strengthening its current pressure ulcer prevention portfolio and providing entry into the negative pressure wound therapy (NPWT) and intermittent pneumatic compression (IPC) therapy markets. The acquisition will complete at the end of February.
Talley Group Ltd., based in Romsey, have a strong UK heritage in the manufacturing of pressure area care equipment, having first incorporated the business in 1953. Talley have successfully built and established a highly regarded brand, developing one of the leading dynamic alternating mattresses in the Quattro range. More recently, Talley have begun manufacturing complimentary ranges within NPWT, IPC, and cleaning and disinfection.
The acquisition of Talley Group Ltd. continues to strengthen DHG’s clinically focused pressure area care division, with the addition of the Quattro and Duocare ranges providing a truly comprehensive portfolio to its customer. The combination of DHG’s and Talley’s expertise in the manufacturing of pressure area care equipment will ensure that its customers will continue to be provided with high quality, cost-effective products that achieve better health outcomes and economic efficiencies. The capacity to rent, service and decontaminate equipment is also significantly enhanced through the acquisition, providing customers with a nationwide coverage of service centres and access to over 70 dedicated Technicians.
Graham Ewart, CEO of Direct Healthcare Group, said: “The acquisition of Talley Group Ltd. continues to position Direct Healthcare Group as a leading provider of solutions that can offer a significantly improved quality of life to those suffering from pressure ulcers. The combination of decades of experience in developing, manufacturing, delivering and maintaining pressure area care products enables us to provide our customers with a unique level of service.”
Further, the acquisition provides Direct Healthcare Group with the opportunity to continue to diversify the ways in which it can significantly impact the lives of those who are affected by reduced mobility.
Graham Ewart: “We continue to recognise the ways in which reduced mobility can lead to both significant harm, but also a reduction in daily living quality. Venous Thromboembolism and chronic wounds are two such areas that we believe we can impact to help support healthcare professionals in managing and preventing these avoidable harms.”
Chris Evans, joint CEO of Talley Group Ltd., said: “The vision and knowledge of Direct Healthcare Group reassures us that Talley’s customers, and the products we have developed over the years, are in the most capable ownership. The development and investment that will be delivered by DHG will accelerate a strong foundation that has been built and provide healthcare providers with solutions that make a clinical difference.”
In December 2019, ArchiMed, a leading independent investment firm specialised in the healthcare industries, bought out Direct Healthcare Group, providing a significant capital commitment to continue to target strategic acquisitions. The acquisitions will have a particular focus on expanding Direct Healthcare Group’s European presence, whilst simultaneously adding clinically effective products that further the company philosophy of advancing movement and health.